Skip to Main Content

Paper Details

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.
Cancers (Basel)
3
2022
CA-125, LGSC, Low-Grade Serous Ovarian Cancer, MVA, Ovarian Cancer, Women, low-grade serous ovarian cancer, women
Author NameAffiliation
Rosalind GlasspoolBeatson West of Scotland Cancer Centre, University of Glasgow
Rosalind GlasspoolInstitute of Cancer Sciences, University of Glasgow
Anna DeFazioThe Westmead Institute for Medical Research
Anna DeFazioPeter MacCallum Cancer Center
Anna DeFazioThe University of Sydney
Anna DeFazioWestmead Hospital
Anna DeFazioThe Westmead Institute for Medical Research
Anna DeFazioWestmead Hospital
Anna DeFazioThe University of Sydney
Anna DeFazioPeter MacCallum Cancer Center
Sharon E JohnattyQIMR Berghofer Medical Research Institute
Diether Lambrechts
Diether LambrechtsVIB Center for Cancer Biology
Joellen M SchildkrautRollins School of Public Health, Emory University
Andrew BerchuckDuke University Hospital
Ellen L GoodeMayo Clinic
Stacey J WinhamMayo Clinic
Beth Y KarlanDavid Geffen School of Medicine, University of California at Los Angeles
Jenny LesterDavid Geffen School of Medicine, University of California at Los Angeles
Marc T GoodmanCedars-Sinai Medical Center
Pamela J ThompsonSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Tanja PejovicOregon Health & Science University
Tanja PejovicKnight Cancer Institute, Oregon Health & Science University
Katherine LajkoszPrincess Margaret Cancer Centre, University of Toronto
  • 1 - 24

Datasets